Although research on the role of non-coding RNAs in regulating the PI3K/AKT signaling pathway in HER2+ BC tumor cells is limited and lacks specificity, numerous studies have demonstrated their important regulatory roles, particularly in breast cancer and TNBC. This evidence concerns the gene ERBB2 and breast cancer.